Cellectar Biosciences Inc (CLRB) — Strategic Asset Allocation Index
Cellectar Biosciences Inc (CLRB) has a Strategic Asset Allocation Index of 10.3% as of December 2022. Strategic assets (PP&E of $978.98K plus long-term investments of $-) total $978.98K, measured against net assets of $9.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Cellectar Biosciences Inc Strategic Asset Allocation Index (2010–2022)
This chart shows how Cellectar Biosciences Inc's Strategic Asset Allocation Index has evolved across 13 annual periods from 2010 to 2022. As of December 2022, the index stands at 10.3%, representing strategic assets of $978.98K against net assets of $9.54 Million USD. Explore CLRB cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Cellectar Biosciences Inc (2010–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Cellectar Biosciences Inc from 2010 to 2022, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Cellectar Biosciences Inc (CLRB) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 10.3% | $978.98K | $978.98K | $- | $9.54 Million | ▲ +8.6 pp |
| 2021 | 1.7% | $549.13K | $549.13K | $- | $33.05 Million | ▲ +0.9 pp |
| 2020 | 0.8% | $430.98K | $355.98K | $75.00K | $54.79 Million | ▼ -4.8 pp |
| 2019 | 5.6% | $510.08K | $435.08K | $75.00K | $9.06 Million | ▼ -2.5 pp |
| 2018 | 8.2% | $1.08 Million | $543.34K | $540.82K | $13.26 Million | ▲ +5.9 pp |
| 2017 | 2.3% | $244.71K | $244.71K | $- | $10.75 Million | ▼ -8.4 pp |
| 2016 | 10.7% | $1.44 Million | $1.44 Million | $- | $13.54 Million | ▼ -94.1 pp |
| 2015 | 104.8% | $1.73 Million | $1.73 Million | $- | $1.65 Million | ▲ +85.8 pp |
| 2014 | 18.9% | $2.03 Million | $2.03 Million | $- | $10.75 Million | ▼ -120.0 pp |
| 2013 | 138.9% | $2.36 Million | $2.36 Million | $- | $1.70 Million | ▲ +112.8 pp |
| 2012 | 26.0% | $2.65 Million | $2.65 Million | $- | $10.16 Million | ▼ -6.1 pp |
| 2011 | 32.1% | $3.04 Million | $3.04 Million | $- | $9.48 Million | ▼ -258.8 pp |
| 2010 | 290.9% | $3.51 Million | $3.51 Million | $- | $1.21 Million | — |